CERRITOS, Calif., July 16, 2019 /PRNewswire/ -- A ceremony will be held on Tuesday, July 23rd at 10:30 am to celebrate the ribbon-cutting of CareAccess MSO (Managed Services Organization) in Cerritos. The office is located within the Plaza Tower at suite 100 and p

WASHINGTON, July 16, 2019 /PRNewswire/ -- Today, the National Women's Law Center (NWLC) launched the Abortion Rights Project to respond to the un

AQUEBOGUE, N.Y., July 16, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Over-the-Counter (OTC) drug products and lots, within expiry, sold by Natural Ophthalmics and TRP Company, Inc. during the time period as indicated in the tables below.  As a precautionary measure, Altaire is voluntarily initiating

SAN JOSE, Calif., July 16, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announces the appointment of Steven M. Bosacki, a 20 year pharmaceutical industry veteran, as its Chief Operating Officer. Mr. Bosacki previ

WASHINGTON, July 16, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that tradipitant, a neurokinin-1 receptor antagonist, was effective in treating motion sickness in a clinical study conducted in the Pacific Ocean.The clinical efficacy results reported today are from the Motion Sifnos Phase II clinical study. In this s

LEAWOOD, Kan., July 16, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the three proposals considered and voted upon by its stockholders at its Special Meeting on July 16,

FARMINGTON, Conn., July 16, 2019 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today t

NEWARK, Calif., July 16, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on July 15, 2019, it issued an inducement award to Sarita Khanna, Ph.D., the Company's recently hired Vice President of Biostatistics, in accordance with the terms of Dr. Khanna's employment offer

PLYMOUTH MEETING, Pa., July 16, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has sharpened its corporate strategy to focus on the commercial development of its late-stage HPV assets and reallocate capital to develop fast-to-market product candidates. The company has cut selected early-stage R&D programs and discontinued

LOS ANGELES, July 16, 2019 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (OTC: IMUC), today announced an agreement with a privately held biotechnology company (the "Purchaser") for the purchase of substantially all of ImmunoCellular's remaining clinical and pre-clinical assets, including its preclinical and clinical programs, technology, intellectu